Stock screenerAll disclosures →
EDGAR →
RCUS
Conviction 51HealthcareScan · Thu, Sep 24, 2026Arcus Biosciences, Inc. (RCUS) closed at $25.04 (-5.12%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 38, RS Rating 93, -20.7% from its 52-week high, +7.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
RCUS$25.04-5.12%
ResistanceSupportVol 14Insider sell2
Vol MA14 2.07M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price25.04
Change-5.12%
Gap-0.57%
Rel volume2.16×
Avg volume1.77M
Avg $ vol46.88M
SMA 2027.24
SMA 5028.20
SMA 20024.74
Price vs 50-11.20%
Price vs 200+1.20%
MA stackmixed
50/200 cross—
Supertrenddown · 27.90
RSI (14)38
MACD hist-0.09
MACD cross—
Stoch %K / %D25 / 38
ADX (14)18
+DI / −DI23 / 31
RSI divergence—
MACD divergence—
ATR %5.44%
ADR %4.74%
52w high31.57
52w low12.37
From 52w high-20.68%
Above 52w low+102.43%
New 52w highNo
SqueezeOff
Bollinger width32.67%
%B0.25
Donchian pos21.20%
Donchian high31.47
Donchian low23.31
AVWAP (52w high)27.97
vs AVWAP high-10.48%
AVWAP (52w low)23.55
vs AVWAP low+6.35%
OBV trendDown
Chaikin MF (20)-0.19
Today vs 20d2.16×
Avg vol (14d)2.07M
Avg vol (20d)1.77M
Avg $ vol (20d)46.88M
Market cap3.19B
RS Rating93 / 99
RS 3m (vs SPY)-21.71%
RS 6m (vs SPY)-0.14%
RS line new highNo
Trend template5/8
Technical rank46.8
1 week-1.96%
1 month-20.68%
3 months-17.22%
6 months+16.68%
1 year+102.10%
YTD+7.51%
P/E-9.03
P/B6.87
P/S96.62
P/FCF-6.59
EPS-3.29
Div yield—
ROE-76.08%
ROA-38.20%
Debt/Eq0.22
Current3.82
EV/EBITDA—
Gross margin—
Net margin—
Rev growth-35.29%
EPS growth-24.73%
Price target38.60
Target upside54.15%
Analyst ratingBuy
Institutional102.80%
Ent. value3.14B
Revenue33M
Net income-91M
Gross profit—
Free cash flow-484M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out125.77M
Employees601
ListedThu, Mar 15, 2018
Free float88.69M
Float %70.8%
Short interest13.08M
Days to cover11.0d
Short volume59.0%
Squeeze score82 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.72 vs −$0.98
Last surprise+26.5% beat
Setup gradeC
Conviction51 / 100
Pattern quality—
Tech rank46.8 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance31.44
Support25.30
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- What Arcus Biosciences Stock New Kidney Cancer Data Means For Shareholderssimplywall.st · Wed, Sep 23, 2026
- (RCUS) as a Liquidity Pulse for Institutional TacticsStock Traders Daily · Wed, Sep 23, 2026
- RCUS Looks 292.6% Overvalued on GF Value™GuruFocus · Tue, Sep 22, 2026
- Cantor Fitzgerald reiterates Arcus Biosciences stock rating By Investing.comInvesting.com Canada · Tue, Sep 22, 2026
- Arcus Biosciences to Host Investor Event Featuring New Data for Casdatifan as a Treatment for Kidney Cancer Across Multiple Lines of TherapyYahoo Finance · Tue, Sep 22, 2026
- Arcus Biosciences stock holds steady as investors eye latest clinical and earnings signalsAD HOC NEWS · Sun, Sep 20, 2026
Congress activity
Disclosed STOCK Act trades in RCUS
No recent disclosed trades by Congress in RCUS. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RCUS · open-market 8 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Azoy Alexander Chief Accounting Officer · Common Stock · 2026-08-21 | Exercise | 2.83K | $44K | 2026-08-21 | 2026-08-24 |
Azoy Alexander Chief Accounting Officer · Common Stock · 2026-08-21 | Sell | 2.83K | $85K | 2026-08-21 | 2026-08-24 |
Azoy Alexander Chief Accounting Officer · Stock Option (right to buy) · 2026-08-21 | Exercise | 2.83K | — | 2026-08-21 | 2026-08-24 |
Jaen Juan C. President · Common Stock · 2026-07-10 | Sell | 19.8K | $566K | 2026-07-10 | 2026-07-13 |
Jaen Juan C. President · Common Stock · 2026-07-10 | Sell | 268 | $8K | 2026-07-10 | 2026-07-13 |
Jaen Juan C. President · Common Stock · 2026-07-09 | Sell | 48.5K | $1.5M | 2026-07-09 | 2026-07-13 |
Jaen Juan C. President · Common Stock · 2026-06-24 | Sell | 6.43K | $191K | 2026-06-24 | 2026-06-24 |
Jaen Juan C. President · Common Stock · 2026-06-23 | Sell | 1.7K | $48K | 2026-06-23 | 2026-06-24 |
Jaen Juan C. President · Common Stock · 2026-06-23 | Sell | 14.07K | $389K | 2026-06-23 | 2026-06-24 |
Jaen Juan C. President · Common Stock · 2026-06-22 | Sell | 9.24K | $250K | 2026-06-22 | 2026-06-24 |
SEC filings
EDGAR filings in RCUS · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.